Sand Hill Angels

VIAN Therapeutics is an early-stage biotechnology company dedicated to innovating treatments for retinal diseases. The company is developing a first-in-class, non-invasive eyedrop intended to replace traditional injections for conditions such as age-related macular degeneration and diabetic macular edema. With robust preclinical data and ongoing clinical trials, VIAN aims to meet significant unmet medical needs in the retinal disease market, which is valued at $15 billion. Additionally, the company is engaged in the creation of peptide drugs that enhance efficacy and safety for treating both ophthalmic and oncology-related conditions by targeting angiogenesis, thereby offering patients improved health outcomes.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Biotia, Inc. is a health tech company based in New York, founded in 2016. It specializes in developing software and laboratory technology that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery. Biotia's solutions focus on microbial surveillance and tailored sequencing to reduce hospital-acquired infections. By enabling clinicians and researchers to identify and stop pathogens before patients fall ill, Biotia aims to improve patient treatment and health outcomes, thereby contributing to safer healthcare environments.

Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

Thread Robotics provides medical devices and services with a focus on fertility care. It was founded in 2020 and operates in Mountain View, California.

Nanochon is focused on creating innovative implantable medical devices designed to address cartilage damage in joints. Utilizing advanced 3D printing techniques and a unique nanomaterial, the company aims to develop solutions that not only replace lost and damaged cartilage but also promote the growth of new tissue. This approach allows medical practitioners to access cost-effective and on-demand devices that enhance treatment outcomes, particularly for young and active patients suffering from knee injuries and diseases. Through its technology, Nanochon seeks to improve the overall quality of care in orthopedics.

Quip NYC, Inc., operating as quip, is an oral healthcare company based in Brooklyn, New York, founded in 2014. The company designs, manufactures, and sells a range of oral care products, including electric toothbrushes, toothpastes, refillable floss pick and string, as well as various supplies such as toothbrush heads and travel covers. Quip is notable for being a pioneer in the direct-to-consumer oral care subscription model, providing customers with fresh supplies delivered every three months. In addition to its product offerings, quip also delivers oral care advice and is developing a technology platform to connect users with a network of dental professionals. Through its online platform, quip aims to make oral health simpler, more accessible, and enjoyable for consumers.

LifeWave is a medical device company based in Los Altos, California, founded in 2000. The company specializes in non-invasive sensing technologies aimed at improving prenatal and neonatal monitoring in both clinical and remote environments. One of its key innovations is the FetalConnect system, which is designed for intrapartum fetal monitoring. Additionally, LifeWave is engaged in creating maternal monitoring solutions to address postpartum hemorrhage. The company also focuses on developing remote guided care solutions specifically for heart failure patients, highlighting its commitment to enhancing healthcare delivery through innovative technology.

Qnovia is a biotechnology company that specializes in developing innovative drug delivery systems, focusing particularly on inhalation-based technologies. The company aims to enhance the delivery of a wide range of pharmaceuticals, including nicotine, by creating advanced aerosol devices and formulations that address the limitations of traditional drug delivery methods. Qnovia's platform not only seeks to improve patient outcomes through more effective inhaled therapies but also emphasizes responsible sourcing and transparency in product information. By prioritizing innovation and patient-centric solutions, Qnovia strives to contribute positively to public health and the overall experience of medication delivery.

Thirty Madison, Inc. is a digital health company based in Astoria, New York, that focuses on providing specialized healthcare solutions for patients with chronic conditions. Founded in 2016, the company operates several condition-specific brands, including Keeps, which offers a subscription-based service for men’s hair loss prevention; Cove, which provides online consultations and prescriptions for migraine treatment; Picnic, targeting allergies; Facet for skin conditions; and NURX for sexual health. Each brand is designed to address the unique needs of its community, offering personalized treatments and support. Thirty Madison emphasizes a human-centered approach, empowering individuals with accessible and effective healthcare solutions tailored to their ongoing conditions.

Elucid, located in the Boston biotech and medtech hub, specializes in enhancing the accuracy and cost-effectiveness of cardiovascular diagnostic imaging through machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software that evaluates plaque vulnerability from a single computed tomography angiography (CTA) scan, aiding in the assessment of heart attack and stroke risk as well as treatment selection. The company also collaborates with pharmaceutical firms, healthcare providers, and research organizations to offer quantitative image analysis services. By applying artificial intelligence to vascular diagnostics, Elucid aims to improve patient outcomes while providing a non-invasive and economically efficient means of capturing critical health information, thereby supporting cardiovascular pathologists in delivering comprehensive clinical insights.

SDIP Innovations specializes in the development and manufacturing of bioresorbable bone implants designed for bone repair and replacement. These innovative implants mimic the natural bone remodeling process, facilitating the healing of fractured bones without the need for surgical removal after their purpose has been served. As the implants are fully absorbed by the body, they promote tissue regeneration while providing a biologically natural and chemically neutral environment conducive to bone renewal. This technology enables surgeons to perform critical surgeries and treat fractures more effectively, enhancing patient recovery and outcomes.

BrightInsight operates a digital health platform tailored for biopharma and medtech companies, focusing on the development and optimization of regulated drugs, devices, and software. Founded in 2017 and headquartered in San Jose, California, the company offers a global regulated platform that utilizes Internet of Things (IoT) technology. This platform facilitates the capture, transmission, and analysis of data from connected medical devices, combination products, and digital therapeutics. By adhering to rigorous security, privacy, and regulatory standards, BrightInsight enables its clients to enhance patient adherence and engagement, streamline their processes, and accelerate time to market while reducing implementation costs. With an additional office in Hägglingen, Switzerland, BrightInsight is positioned to support customers in navigating the complexities of the digital health landscape.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Lambs is a business that specializes in designing and manufacturing protective apparel, primarily focusing on undergarments. Their signature product is high-tech boxers designed to shield the testicles and sperm from radiation emitted by smartphones and Wi-Fi. The company uses advanced material science and performance fabrics to ensure both protection and everyday comfort. In addition to boxers, Lambs offers a range of products including t-shirts, socks, and face masks, all aimed at safeguarding customers from wireless radiation.

Alertive Healthcare is a digital healthcare company focused on addressing the hypertension epidemic and managing chronic diseases. The company has developed a remote healthcare management platform that enables healthcare providers to monitor patients' blood pressure between doctor visits. By utilizing data from FDA-approved, Bluetooth-enabled blood pressure devices, Alertive facilitates effective communication among care teams, allowing for timely clinical recommendations. This innovative approach significantly reduces the time required to achieve blood pressure control, cutting it down from the standard 18-24 months to as little as 10 weeks, ultimately helping patients lead healthier lives.

Medly Pharmacy is a digital pharmacy based in Brooklyn, New York, with an additional office in New Jersey. Founded in 2017, it operates under the parent company Medly Health and offers free same-day prescription delivery services across New York City and New Jersey. The company provides comprehensive services including refill management, coordination with doctors and insurance, prior authorization support, consultations, and financial assistance. Medly Pharmacy combines dedicated customer service with extensive pharmacy expertise to personalize patient care journeys.

NS Nanotech Inc., founded in 2018 and located in Ann Arbor, Michigan, specializes in developing innovative nano-LED technology for various applications, including display systems, UV sterilization, and carbon water splitting. The company has patented nitride semiconductors that produce light in both the visible RGB spectrum and the invisible UV spectrum, targeting next-generation display technology, such as signage, mobile devices, augmented reality, virtual reality, and high-definition televisions. NS Nanotech's solid-state technology aims to replace traditional germicidal UVC lamps, which are often large, fragile, and costly, and typically contain hazardous materials like mercury. The company's nano-LED products utilize nanowires in photonic crystal structures to achieve efficient battery life and cost-effective device fabrication, making them suitable for air, surface, and water purification applications.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Imprint Energy, Inc. develops and commercializes innovative zinc-based rechargeable battery technology aimed at enhancing portable power solutions. The company offers ZincPoly batteries, which address the limitations of traditional zinc batteries and enable the production of rechargeable options. These batteries are designed for a variety of small portable electronics, including mobile accessories, compact wireless devices, wearables, and medical equipment. Founded in 2010 and based in Alameda, California, Imprint Energy focuses on providing flexible, high-energy-density batteries that deliver lithium-like performance at lower costs, while also prioritizing safety and scalability through a unique print-based manufacturing process. This breakthrough technology positions Imprint Energy to meet the evolving energy needs of contemporary and future electronic devices.

Quip NYC, Inc., operating as quip, is an oral healthcare company based in Brooklyn, New York, founded in 2014. The company designs, manufactures, and sells a range of oral care products, including electric toothbrushes, toothpastes, refillable floss pick and string, as well as various supplies such as toothbrush heads and travel covers. Quip is notable for being a pioneer in the direct-to-consumer oral care subscription model, providing customers with fresh supplies delivered every three months. In addition to its product offerings, quip also delivers oral care advice and is developing a technology platform to connect users with a network of dental professionals. Through its online platform, quip aims to make oral health simpler, more accessible, and enjoyable for consumers.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.

Thirty Madison, Inc. is a digital health company based in Astoria, New York, that focuses on providing specialized healthcare solutions for patients with chronic conditions. Founded in 2016, the company operates several condition-specific brands, including Keeps, which offers a subscription-based service for men’s hair loss prevention; Cove, which provides online consultations and prescriptions for migraine treatment; Picnic, targeting allergies; Facet for skin conditions; and NURX for sexual health. Each brand is designed to address the unique needs of its community, offering personalized treatments and support. Thirty Madison emphasizes a human-centered approach, empowering individuals with accessible and effective healthcare solutions tailored to their ongoing conditions.

Volumetric, Inc. is a Houston-based company that specializes in advanced biomaterials and biofabrication through its innovative 3D bioprinting platform. Founded in 2014, Volumetric focuses on creating vascularized human tissue and developing bioprinters and bio inks for a range of applications, including life sciences, drug discovery, and medical devices. The company's technology aims to enhance research in biomaterials, cancer treatments, and the potential replacement of human organs, positioning it at the forefront of developments in regenerative medicine and tissue engineering.

Fitnescity is a consumer health platform that simplifies access to health and wellness testing services. The company offers a range of test kits that are utilized by prominent laboratories, hospitals, and clinics across the country. These kits facilitate consumer-facing tests, including assessments for vitamin D, testosterone, glucose, body composition, creatinine, and resting metabolic rate. By providing both at-home and in-person testing options, Fitnescity enables individuals to easily navigate their health and fitness needs, empowering them to make informed decisions regarding their wellness and performance.

Siren Care, Inc. is a health technology company based in San Francisco, California, founded in 2015. It specializes in wearable devices designed for diabetic health tracking, particularly through its flagship product, the Siren diabetic socks. These smart socks continuously monitor foot temperature, providing crucial data that can help detect early signs of diabetic ulcers, thereby reducing the risk of amputations. The temperature data is transmitted via an application, allowing healthcare providers to monitor patients effectively and intervene early if necessary. Siren Care aims to enhance healthcare for individuals with chronic diseases by collaborating with both providers and payers to improve patient outcomes in diabetic foot care.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Alertive Healthcare is a digital healthcare company focused on addressing the hypertension epidemic and managing chronic diseases. The company has developed a remote healthcare management platform that enables healthcare providers to monitor patients' blood pressure between doctor visits. By utilizing data from FDA-approved, Bluetooth-enabled blood pressure devices, Alertive facilitates effective communication among care teams, allowing for timely clinical recommendations. This innovative approach significantly reduces the time required to achieve blood pressure control, cutting it down from the standard 18-24 months to as little as 10 weeks, ultimately helping patients lead healthier lives.

Anzu is an exciting, fast-growing startup founded by a group of physicians and technologists with a shared vision for creating inspiring products to benefit medical practices, doctors and patients. Headquartered in Phoenix, with operations in Boston, Silicon Valley and India, Anzu is privately held.

Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.

Volumetric, Inc. is a Houston-based company that specializes in advanced biomaterials and biofabrication through its innovative 3D bioprinting platform. Founded in 2014, Volumetric focuses on creating vascularized human tissue and developing bioprinters and bio inks for a range of applications, including life sciences, drug discovery, and medical devices. The company's technology aims to enhance research in biomaterials, cancer treatments, and the potential replacement of human organs, positioning it at the forefront of developments in regenerative medicine and tissue engineering.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Mechanodontics, Inc. is a Dallas, Texas-based company established in 2016 that specializes in the manufacture of a discreet dental device designed to move teeth independently. This innovative method serves as an alternative to traditional braces and aligners, offering significant advantages such as reduced treatment time, improved ease of cleaning, and enhanced comfort. The device is placed behind the teeth, making it virtually invisible, and is engineered to work on each tooth individually, allowing for more precise adjustments.

Mindshare Medical, Inc. develops clinical decision support technology aimed at enhancing diagnostics and guiding healthcare providers in follow-up procedures and treatments. Founded in May 2014 by Samir Chowdhury and Michael Calhoun, the company is headquartered in San Juan Capistrano, California. Its proprietary solutions focus on improving the detection and characterization of diseases, including assessing their severity and progression. By providing evidence-based insights, Mindshare Medical aims to elevate the quality of patient care and reduce financial risks for healthcare organizations.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

NS Nanotech Inc., founded in 2018 and located in Ann Arbor, Michigan, specializes in developing innovative nano-LED technology for various applications, including display systems, UV sterilization, and carbon water splitting. The company has patented nitride semiconductors that produce light in both the visible RGB spectrum and the invisible UV spectrum, targeting next-generation display technology, such as signage, mobile devices, augmented reality, virtual reality, and high-definition televisions. NS Nanotech's solid-state technology aims to replace traditional germicidal UVC lamps, which are often large, fragile, and costly, and typically contain hazardous materials like mercury. The company's nano-LED products utilize nanowires in photonic crystal structures to achieve efficient battery life and cost-effective device fabrication, making them suitable for air, surface, and water purification applications.

LifeWave is a medical device company based in Los Altos, California, founded in 2000. The company specializes in non-invasive sensing technologies aimed at improving prenatal and neonatal monitoring in both clinical and remote environments. One of its key innovations is the FetalConnect system, which is designed for intrapartum fetal monitoring. Additionally, LifeWave is engaged in creating maternal monitoring solutions to address postpartum hemorrhage. The company also focuses on developing remote guided care solutions specifically for heart failure patients, highlighting its commitment to enhancing healthcare delivery through innovative technology.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

JUUL is an electronics company based in San Francisco, California, that focuses on providing alternatives for adult smokers through its nicotine vaporizer products. The company aims to eliminate combustible cigarettes by offering a satisfying and less harmful option for the estimated one billion smokers worldwide. JUUL's product line includes e-cigarettes and a variety of free-base nicotine flavors made from natural oils and extracts, designed to help users transition from traditional tobacco smoking. Research conducted by JUUL indicates that hundreds of thousands of smokers have successfully switched to their products, with the company committed to facilitating this transition for millions more in the future.

InnoVein, Inc. is a medical device company founded in 2015 and based in San Carlos, California. The company specializes in developing an implantable valve designed to regulate blood flow in the veins, particularly targeting elderly patients suffering from venous insufficiency disease. With a focus on advancing cardiac and arterial health, InnoVein aims to address critical needs in vascular treatment through its innovative product offerings.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Kenzen, Inc. specializes in health and performance monitoring through its innovative Kenzen ECHO system, which includes a wireless smart patch designed to provide real-time feedback on vital signs, motion, and performance. The smart patch continuously monitors critical parameters to detect heat-related injuries and alert both users and safety supervisors, thereby enhancing workplace safety. Kenzen ECHO also incorporates a mobile application that delivers personalized health insights, aiding in performance improvement and injury prevention. The company, which was incorporated in 2014 and is based in New York, markets its products through various distributors, resellers, and retail locations. Its mission focuses on leveraging physiological data to predict and prevent injuries among industrial workers, ultimately boosting productivity and ensuring safer work environments.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. This technology allows healthcare professionals to detect and monitor blood concentrations, facilitating timely and appropriate therapy for patients requiring critical care in clinical settings. Founded in 2015 and based in El Cerrito, California, ProbiusDx aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

TheraDep specializes in the development of surface coatings for microneedles and labware, targeting the medical device and pharmaceutical sectors. The company creates biocompatible coatings that are drug-eluting, growth-promoting, and therapeutic, utilizing a patented process to meet the specific requirements of its clients. By collaborating with medical device and labware manufacturers, TheraDep aims to deliver innovative drug delivery solutions that enhance patient treatment outcomes.

JUUL is an electronics company based in San Francisco, California, that focuses on providing alternatives for adult smokers through its nicotine vaporizer products. The company aims to eliminate combustible cigarettes by offering a satisfying and less harmful option for the estimated one billion smokers worldwide. JUUL's product line includes e-cigarettes and a variety of free-base nicotine flavors made from natural oils and extracts, designed to help users transition from traditional tobacco smoking. Research conducted by JUUL indicates that hundreds of thousands of smokers have successfully switched to their products, with the company committed to facilitating this transition for millions more in the future.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Tivic Health is a bioelectronic therapeutics company that specializes in developing non-invasive medical devices aimed at enhancing healthcare through neuroscience. The company focuses on creating consumer-friendly products that activate the body's natural healing mechanisms, offering an alternative to traditional pharmaceutical treatments. Its flagship product, ClearUP Sinus Pain Relief, is a patented handheld device designed to provide temporary relief from sinus pain and congestion associated with nasal allergies and sinus infections. The device employs ultra-low current electrical waves and has been clinically validated for its efficacy. Tivic Health received FDA clearance for ClearUP in January 2019, with the product set to be shipped starting in September 2019.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

TheraDep specializes in the development of surface coatings for microneedles and labware, targeting the medical device and pharmaceutical sectors. The company creates biocompatible coatings that are drug-eluting, growth-promoting, and therapeutic, utilizing a patented process to meet the specific requirements of its clients. By collaborating with medical device and labware manufacturers, TheraDep aims to deliver innovative drug delivery solutions that enhance patient treatment outcomes.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), an innovative imaging technology that utilizes iron oxide nanoparticle tracers and time-varying magnetic fields. The company has developed several products, including the MOMENTUM imager, a pre-clinical MPI solution that produces high-quality images through advanced magnet geometry and a proprietary reconstruction process. Additionally, Magnetic Insight offers VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies, and Hyper, an add-on module for the MOMENTUM system that assists in identifying treatment targets and administering localized magnetic hyperthermia. Another product, Relax, serves as a particle relaxometry module. Founded in 2012 and headquartered in Alameda, California, Magnetic Insight aims to enhance preclinical diagnostic research by enabling quantitative cell tracking, imaging of vascular functions, and visualization of various biological processes, thereby addressing challenges in clinical and translational research.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

JUUL is an electronics company based in San Francisco, California, that focuses on providing alternatives for adult smokers through its nicotine vaporizer products. The company aims to eliminate combustible cigarettes by offering a satisfying and less harmful option for the estimated one billion smokers worldwide. JUUL's product line includes e-cigarettes and a variety of free-base nicotine flavors made from natural oils and extracts, designed to help users transition from traditional tobacco smoking. Research conducted by JUUL indicates that hundreds of thousands of smokers have successfully switched to their products, with the company committed to facilitating this transition for millions more in the future.

Nanotech Biomachines specializes in the development of advanced sensor technology aimed at transforming therapeutic discovery and development processes. By utilizing modern electronic materials and straightforward membrane preparations, the company achieves high sensitivity and specificity in its measurements. Its innovative approach employs naive biology to enable real-time, mass-independent, cell-free, and label-free detection of interactions with integral membrane proteins (IMPs). This technology offers a direct electronic output and utilizes native IMPs within fluid membranes, providing essential tools for clients engaged in the discovery and development of 21st-century medicines.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

Nanotech Biomachines specializes in the development of advanced sensor technology aimed at transforming therapeutic discovery and development processes. By utilizing modern electronic materials and straightforward membrane preparations, the company achieves high sensitivity and specificity in its measurements. Its innovative approach employs naive biology to enable real-time, mass-independent, cell-free, and label-free detection of interactions with integral membrane proteins (IMPs). This technology offers a direct electronic output and utilizes native IMPs within fluid membranes, providing essential tools for clients engaged in the discovery and development of 21st-century medicines.

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

Sandstone Diagnostics, Inc. is a technology and healthcare company based in Pleasanton, California, founded in 2012. The company specializes in developing medical products and research tools focused on male fertility management. Its notable offerings include the Torq ZDrive, which separates blood cells from liquid plasma at the point of collection, and the Torq Microvolume Rotor, a remote blood sampling device for diagnostic testing. Sandstone also manufactures the Trak fertility system, which consists of an engine, a disposable test plate, a sample collection cup, and a dropper, allowing men to monitor their sperm quality and enhance their fertility potential. Additionally, the company provides a mobile application that allows users to track fertility statistics over time, identify potential fertility issues, and take proactive steps to improve their reproductive health. Through these innovations, Sandstone Diagnostics aims to empower individuals to manage their fertility from the comfort of their own homes.

RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

Figure 8 Surgical, Inc. is a medical technology company based in Palo Alto, California, founded in 2009. It specializes in the development of surgical devices, notably a sternum repair device designed to enhance the closure of the sternum following open-heart surgery. This FDA-approved device offers a cost-effective alternative to traditional steel wire, maintaining the simplicity of wire cerclage while providing superior multi-vector strength and ease of placement. By enabling surgeons to achieve more stable closures, Figure 8's device aims to reduce complications and improve patient outcomes in cardiac procedures.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

OncoHealth is a company that specializes in creating screening devices aimed at the detection and diagnosis of cancer. The primary focus of its devices is the development of protein bio-markers, which are essential for the screening and diagnostic processes related to cervical cancer and other cancers associated with human papillomavirus (HPV). By advancing these technologies, OncoHealth enables medical professionals to effectively monitor, diagnose, and treat cancer, thereby contributing to improved patient outcomes in oncology.

Figure 8 Surgical, Inc. is a medical technology company based in Palo Alto, California, founded in 2009. It specializes in the development of surgical devices, notably a sternum repair device designed to enhance the closure of the sternum following open-heart surgery. This FDA-approved device offers a cost-effective alternative to traditional steel wire, maintaining the simplicity of wire cerclage while providing superior multi-vector strength and ease of placement. By enabling surgeons to achieve more stable closures, Figure 8's device aims to reduce complications and improve patient outcomes in cardiac procedures.

Niveus Medical, Inc. is a company that specializes in muscle stimulation systems aimed at preventing muscle atrophy, particularly in patients who are sedated or on bed rest. Founded in 2008 and based in Redwood City, California, Niveus Medical develops technologies that stimulate the quadriceps, facilitating the maintenance or increase of knee joint range of motion. Their systems are designed to re-educate muscles, alleviate spasms, and enhance local blood circulation. By providing effective stimulation, Niveus Medical's products enable faster treatment initiation, ultimately improving the chances of successful patient recovery in intensive care settings. The company operates under the brand IntelliSTIM.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

Figure 8 Surgical, Inc. is a medical technology company based in Palo Alto, California, founded in 2009. It specializes in the development of surgical devices, notably a sternum repair device designed to enhance the closure of the sternum following open-heart surgery. This FDA-approved device offers a cost-effective alternative to traditional steel wire, maintaining the simplicity of wire cerclage while providing superior multi-vector strength and ease of placement. By enabling surgeons to achieve more stable closures, Figure 8's device aims to reduce complications and improve patient outcomes in cardiac procedures.

OncoHealth is a company that specializes in creating screening devices aimed at the detection and diagnosis of cancer. The primary focus of its devices is the development of protein bio-markers, which are essential for the screening and diagnostic processes related to cervical cancer and other cancers associated with human papillomavirus (HPV). By advancing these technologies, OncoHealth enables medical professionals to effectively monitor, diagnose, and treat cancer, thereby contributing to improved patient outcomes in oncology.

Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

Figure 8 Surgical, Inc. is a medical technology company based in Palo Alto, California, founded in 2009. It specializes in the development of surgical devices, notably a sternum repair device designed to enhance the closure of the sternum following open-heart surgery. This FDA-approved device offers a cost-effective alternative to traditional steel wire, maintaining the simplicity of wire cerclage while providing superior multi-vector strength and ease of placement. By enabling surgeons to achieve more stable closures, Figure 8's device aims to reduce complications and improve patient outcomes in cardiac procedures.

OncoHealth is a company that specializes in creating screening devices aimed at the detection and diagnosis of cancer. The primary focus of its devices is the development of protein bio-markers, which are essential for the screening and diagnostic processes related to cervical cancer and other cancers associated with human papillomavirus (HPV). By advancing these technologies, OncoHealth enables medical professionals to effectively monitor, diagnose, and treat cancer, thereby contributing to improved patient outcomes in oncology.

Catheter Connections, Inc. specializes in developing vascular access products aimed at preventing infections during intravenous infusion therapy. Founded in 2008 and based in Salt Lake City, Utah, the company offers the DualCap System, which includes user-friendly, single-use disinfecting caps designed to protect IV catheter access points. The system helps healthcare facilities combat IV catheter-related bloodstream infections by effectively disinfecting IV tubing end connectors and needle-free valves. Catheter Connections markets its products through a network of sales representatives, focusing on providing integrated solutions for infection control in healthcare settings across the United States. As of early 2017, the company operates as a subsidiary of Merit Medical Systems, Inc.

IMI Intelligent Medical Implants develops and markets intelligent retinal implant systems for degenerative retinal disorders. The company offers The Intelligent Retinal Implant System, an adaptive visual prosthesis that bridges and replaces the defective information processing function of the real retina in patients with retinal degeneration. IMI Intelligent Medical Implants was founded in 2002 and is based in Zug, Switzerland.